No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $102 Price Target
Truist Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $120
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $95 to $105
Viking Therapeutics Begins VK2735 Phase II Trial for Obesity Treatment
Viking Therapeutics: Strategic Positioning and Promising Development of Oral 2735 Drive Buy Rating
Positive Outlook for Viking Therapeutics Amid Promising Trial Developments